| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/27/2005 | EP1556493A1 Novel full-length genomic rna of japanese encephalitis virus, infectious jev cdna therefrom, and use thereof |
| 07/27/2005 | EP1556487A2 Transplantable cell |
| 07/27/2005 | EP1556484A2 Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model: uses in human neurological diseases |
| 07/27/2005 | EP1556411A2 Viral vectors and the use of the same for gene therapy |
| 07/27/2005 | EP1556402A2 In vivo gene silencing by chemically modified and stable sirna |
| 07/27/2005 | EP1556080A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1555874A2 Gene regulation with aptamer and modulator complexes for gene therapy |
| 07/27/2005 | EP1501922A4 Methods of modulating heme oxygenase-1 expression and treating heme oxygenase-1 mediated conditions |
| 07/27/2005 | EP1320295A4 Collagen/polysaccharide bilayer matrix |
| 07/27/2005 | EP1206539B1 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 07/27/2005 | EP1144014B1 Composition and method for obtaining specific immunisation against one or more antigens using different recombinant vectors |
| 07/27/2005 | EP1025236B1 Human checkpoint kinase, hcds1, compositions and methods |
| 07/27/2005 | EP0952855B1 Use of hyaluronan in gene therapy |
| 07/27/2005 | CN1646703A Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 07/27/2005 | CN1646693A Enveloped microorganism |
| 07/27/2005 | CN1646692A Genetic products differentially expressed in tumors and use thereof |
| 07/27/2005 | CN1646688A Growth regulating proteins |
| 07/27/2005 | CN1646563A Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/27/2005 | CN1646174A Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 07/27/2005 | CN1646162A Use of an inhibitor or antagonist against tissue factor |
| 07/27/2005 | CN1646157A Multiple and multivalent DNA vaccines in ovo |
| 07/27/2005 | CN1646155A Cancer therapy |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646153A Active antiangiogenic therapy |
| 07/27/2005 | CN1646097A Chemosensitizing with liposomes containing oligonucleotides |
| 07/27/2005 | CN1646020A Methods and composition for delivering nucleic acids and/or proteins to the respiratory system |
| 07/27/2005 | CN1644701A Tumour cell specific eucaryon expressing carriers |
| 07/27/2005 | CN1212398C Novel IFN receptor 1 binding proteins, DNA encoding them, and method of modulating cellular response to interferons |
| 07/27/2005 | CN1212155C CD 40 binding molecules and CTL peptides for treating tumors |
| 07/26/2005 | US6921665 Generation of differentiaed cells; obtain stem cells, transform with vector coding preferential proteins and reporter molecules, deplete undifferentiated stem cells from culture pool, recover differentiated cells |
| 07/26/2005 | US6921664 Telomerase |
| 07/26/2005 | US6921663 Adenovirus vector |
| 07/26/2005 | US6921644 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders |
| 07/26/2005 | US6921634 Detecting viricidal compounds which inhibit duplication of RNA sequences; fusion proteins; antiproliferative agents |
| 07/26/2005 | US6921536 Lawsonia intracellularis vaccine |
| 07/26/2005 | US6921534 Hepatitis B virus treatment |
| 07/26/2005 | CA2005567C Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system |
| 07/22/2005 | CA2455659A1 Barhl2 proteins, genes encoding the same and uses thereof |
| 07/21/2005 | WO2005066371A2 Methods for predicting and overcoming resistance to chemotherapy in ovarian cancer and for predicting colon cancer occurrence |
| 07/21/2005 | WO2005066330A1 A system for improving acceptance of tissue grafts made from embryonic stem cells |
| 07/21/2005 | WO2005066212A1 Pseudoproteoglycan and use thereof |
| 07/21/2005 | WO2005065722A2 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 07/21/2005 | WO2005065721A2 Use of an anti-inflammatory compound for the reduction of inflammation secondary to the administration of a lipid-nucleic acid complex |
| 07/21/2005 | WO2005065720A1 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same |
| 07/21/2005 | WO2005065719A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer |
| 07/21/2005 | WO2005065309A2 Lentiviral vector delivery of native and mutated igfbp-3 for treatment of cancer |
| 07/21/2005 | WO2005065268A2 Oligonucleotide compound and method for treating nidovirus infections |
| 07/21/2005 | WO2005065121A2 Methods and compositions for the production of monoclonal antibodies |
| 07/21/2005 | WO2005047473A3 Single vector dual gene therapy for pulmonary hypertension |
| 07/21/2005 | WO2005042018A3 C-class oligonucleotide analogs with enhanced immunostimulatory potency |
| 07/21/2005 | WO2005007819A3 Charge-dynamic polymers and delivery of anionic compounds |
| 07/21/2005 | WO2004060274A3 Treatment of dry eye by restoring 15-lipoxygenase activity to ocular surface cells |
| 07/21/2005 | WO2004018648A3 Methods for treating patients and identifying therapeutics |
| 07/21/2005 | US20050159590 Variants of interleukin-1 receptor antagonist: compositions and uses thereof |
| 07/21/2005 | US20050159375 Novel oligonucleotides and related compounds |
| 07/21/2005 | US20050159373 Novel polypeptides, and nucleic acids encoding the same |
| 07/21/2005 | US20050159357 Treatment of rheumatoid arthritis with soluble Fas-ligand cross-linkers |
| 07/21/2005 | US20050158826 Using tumor necrosis factor receptor releasing enzyme as therapeutic tool in treatment of inflammation, arthritis, rheumatoid arthritis and multiple sclerosis |
| 07/21/2005 | US20050158824 Using chinese hamster ovaries as bioreactor for production of nerve growth factor for use in prevention and treatment of nervous system disorders |
| 07/21/2005 | US20050158785 Non-peptide compounds 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; for use in bioassay, fluorescent quantitative analysis; control of gene expression, treatment/prevention of cancer |
| 07/21/2005 | US20050158784 Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof |
| 07/21/2005 | US20050158778 Transcription factor for use in generating immoglobulin for prevention and treatment of fungal infection |
| 07/21/2005 | US20050158775 Transgenic animal cell comprising expression vector coding transmembrane/fatty acid synthase fusion for use as model in prevention and treatment of cancer or/an autoimmune disease |
| 07/21/2005 | US20050158757 Methods for the early diagnosis of ovarian cancer |
| 07/21/2005 | US20050158727 Derivatized oligonucleotides having improved uptake and other properties |
| 07/21/2005 | US20050158726 Compositons and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
| 07/21/2005 | US20050158724 Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| 07/21/2005 | US20050158714 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 07/21/2005 | US20050158712 Methods for purifying viral particles for gene therapy |
| 07/21/2005 | US20050158379 Minimization of drug oxidation in drug irradiated excipients formulations |
| 07/21/2005 | US20050158373 Method and carrier complexes for delivering molecules to cells |
| 07/21/2005 | US20050158372 Immunoliposome-nucleic acid amplification (ILNAA) assay |
| 07/21/2005 | US20050158336 Antigenic peptides, e.g. fusion peptides of CTL epitope peptides and a T helper peptide, conjugated to an immunostimulatory DNA oligomer; cytosine-phosphate-guanosine (CpG); enhanced recognition of the substance by the immune system e.g. HIV vaccines, cancer vaccines |
| 07/21/2005 | US20050158327 Interrupting the interaction of intercellular adhesion molecule-1 and respiratory syncytial virus for prevention and treatment of infection |
| 07/21/2005 | US20050158321 Drug screening; for methotrexate resistant patients |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158311 Via contacting cell with agent that binds Ryk polypeptides, inhibiting signal transduction; for amelioration of cancer |
| 07/21/2005 | US20050158310 Via modulating insulin receptor signaling in adipocyte tissue; transgenic/knockout animal; RNA interference |
| 07/21/2005 | US20050158309 Gonadotropin-releasing hormone (gnrh); gene expression inhibition; for treatment of T-cell related neoplastic diseases |
| 07/21/2005 | US20050158302 Methods for diagnosing and treating autoimmune disease |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/21/2005 | US20050158287 Methods for using the obese gene and its gene product to identify hematopoietic progenitor cells |
| 07/21/2005 | US20050158282 epidermal growth factor (EGF) producing Lactococcus lactis and Lactobacillus casei ( lactic acid bacterium); useful to treat Short Bowel Syndrome; increase intestinal villi height |
| 07/21/2005 | US20050158281 vascular permeability agents (VPAs), such as VEGF, used in conjunction with adeno-associated virus(AVV) a nucleic acid viral vectors; nucleic cid sequences encoding Igf-1( insulin like growth factor-1) and dystrophin or dystrophin-like proteins; muscular disorders |
| 07/21/2005 | US20050158280 Method of reducing angiogenesis |
| 07/21/2005 | US20050158279 Administering a negative-strand RNA viral vector (sendai virus) containing FGF-1 or FGF-5 (fibroblast growth factors) as a foreign gene to animals; gene therapy |
| 07/21/2005 | US20050158278 Means and methods for the production of adenovirus vectors |
| 07/21/2005 | DE10024383B4 Mit toxischen Substanzen beladene dendritische Zellen With toxic substances loaded dendritic cells |
| 07/21/2005 | CA2592891A1 Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation |
| 07/21/2005 | CA2553211A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in combination therapies for the treatment of cancer |
| 07/21/2005 | CA2552188A1 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof |
| 07/21/2005 | CA2550642A1 Oligonucleotide compound and method for treating nidovirus infections |
| 07/21/2005 | CA2548179A1 Methods and compositions for the production of monoclonal antibodies |
| 07/20/2005 | EP1555319A2 Modified nucleic acid sequences and method to increasing mRNA levels and protein expression in cell systems |
| 07/20/2005 | EP1555317A1 Synthetic genes and genetic constructs comprising the same |
| 07/20/2005 | EP1555316A2 Antigen library immunization |
| 07/20/2005 | EP1555033A2 Polynucleotide composition, method of preparation, and use thereof |
| 07/20/2005 | EP1555030A1 Sustained release preparation for treating coronary stenosis or obstruction |
| 07/20/2005 | EP1554405A1 Compositions, methods, and kits relating to behab and primary cns tumors |